Go to homepage
Holoclara
Holoclara
Overview
Overview
Governance
Governance
Press
Press
Contact
June 27, 2024
Holoclara announces $16M Series A Financing to advance a breakthrough class of worm-derived therapeutics for allergic and autoimmune disease.
Share
Share this article
